Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
Reuters
Tue, 04/24/18 - 10:47 pm
Express Scripts
migraines
PBMs
Amgen
Eli Lilly
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Fierce Pharma
Tue, 04/24/18 - 10:44 pm
Eli Lilly
earnings
baricitinib
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Mon, 04/23/18 - 11:15 pm
Eli Lilly
FDA
advisory panels
rheumatoid arthritis
baricitinib
Incyte
Big Week Ahead for Eli Lilly: Here's What to Look For
Motley Fool
Sun, 04/22/18 - 12:12 pm
Eli Lilly
earnings
FDA
Incyte
olumiant
rheumatoid arthritis
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms
Xconomy
Fri, 04/20/18 - 09:30 am
Eli Lilly
baricitinib
olumiant
rheumatoid arthritis
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Fri, 04/13/18 - 08:52 am
Pfizer
M&A
Bristol-Myers Squibb
Celgene
Eli Lilly
AstraZeneca
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Drug Channels
Thu, 04/5/18 - 08:59 am
Eli Lilly
Janssen
Merck
drug pricing
drug discounts
Pharma turns to new pain options amid opioid crisis
Biopharma Dive
Thu, 04/5/18 - 08:58 am
opioids
opioid crisis
painkillers
payers
Eli Lilly
abuse deterrents
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Drug Delivery Business News
Wed, 04/4/18 - 09:08 am
Eli Lilly
Sigilon
cell therapies
drug development
type 1 diabetes
Lilly's Cyramza succeeds in late-stage liver cancer trial
Yahoo/Reuters
Wed, 04/4/18 - 08:55 am
Eli Lilly
Cyramza
liver cancer
clinical trials
Tired of finishing in last place, Eli Lilly’s new R&D chief wants to shake things up
Endpoints
Mon, 04/2/18 - 12:12 pm
Eli Lilly
R&D
Dan Skovronsky
Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017
Fierce Pharma
Sat, 03/31/18 - 09:56 am
Eli Lilly
drug rebates
drug pricing
diabetes
Investors in AbbVie, Lilly, Amgen and more set to vote on executive pay, drug pricing
Fierce Pharma
Tue, 03/27/18 - 10:00 pm
AbbVie
Eli Lilly
Amgen
executive pay
drug pricing
Lilly's bet on pain stands out amid bare pharma pipeline
Biopharma Dive
Mon, 03/26/18 - 09:58 pm
Eli Lilly
painkillers
galcanezumab
tanezumab
Lasmiditan
CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business
Morningstar
Tue, 03/20/18 - 03:31 pm
CVS
Eli Lilly
PBMs
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
Endpoints
Fri, 03/9/18 - 10:48 am
Eli Lilly
Merck KGaA
Btk inhibitors
autoimmune disease
evobrutinib
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Fierce Pharma
Wed, 03/7/18 - 12:00 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
exercise
diabetes
Migraine maven Lilly finds 'understanding gap' between patients, nonpatients in new survey
Fierce Pharma
Mon, 03/5/18 - 09:45 am
migraines
Eli Lilly
patients
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Yahoo/Market Exclusive
Tue, 02/27/18 - 09:48 am
Eli Lilly
Zosano
Verzenio
advanced breast cancer
M207
migraine
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Drug Delivery Business News
Mon, 02/26/18 - 07:27 pm
Eli Lilly
diabetes
clinical trials
Trulicity
Pages
« first
‹ previous
…
56
57
58
59
60
61
62
63
64
…
next ›
last »